93 related articles for article (PubMed ID: 22079036)
1. Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection.
Núñez EG; de Oliveira EA; da Silva NG; Filho RS
Nucl Med Biol; 2012 Jan; 39(1):145-53. PubMed ID: 22079036
[TBL] [Abstract][Full Text] [Related]
2. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs.
Méndez J; Wallace AM; Hoh CK; Vera DR
J Nucl Med; 2003 Oct; 44(10):1677-81. PubMed ID: 14530486
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping.
Ellner SJ; Hoh CK; Vera DR; Darrah DD; Schulteis G; Wallace AM
Nucl Med Biol; 2003 Nov; 30(8):805-10. PubMed ID: 14698783
[TBL] [Abstract][Full Text] [Related]
4. Comparative biological evaluation of two [99mTc(CO)3]-dextran pyrazolyl mannose conjugates developed for use in sentinel lymph node detection.
Subramanian S; Pandey U; Morais M; Correia JD; Santos I; Samuel G
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):216-23. PubMed ID: 24172653
[TBL] [Abstract][Full Text] [Related]
5. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
Vera DR; Wallace AM; Hoh CK; Mattrey RF
J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562
[TBL] [Abstract][Full Text] [Related]
6. Studying the biological feasibility of [⁹⁹mTc(CO)₃]-dextran-cysteine-cysteine-mannose as a potential molecular radiopharmaceutical for sentinel node detection.
Khan IU; Shahid A; Ahmad F; Dar UK; Ahmad M; Javed M
Ann Nucl Med; 2014 Apr; 28(3):248-56. PubMed ID: 24390658
[TBL] [Abstract][Full Text] [Related]
7. Studies toward the biological efficacy of (99m)Tc-labeled dextran-cysteine-mannose ([(99m)Tc(CO)(3)]DCM20) for sentinel lymph node detection.
Subramanian S; Pandey U; Papadopoulos M; Pirmettis I; Venkatesh M; Samuel G
Cancer Biother Radiopharm; 2012 Aug; 27(6):365-70. PubMed ID: 22690877
[TBL] [Abstract][Full Text] [Related]
8. Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection.
Giglio J; Fernández S; Jentschel C; Pietzsch HJ; Papadopoulos M; Pelecanou M; Pirmettis I; Paolino A; Rey A
Cancer Biother Radiopharm; 2013 Sep; 28(7):541-51. PubMed ID: 23651043
[TBL] [Abstract][Full Text] [Related]
9. New (99m)Tc(CO)(3) mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection.
Pirmettis I; Arano Y; Tsotakos T; Okada K; Yamaguchi A; Uehara T; Morais M; Correia JD; Santos I; Martins M; Pereira S; Triantis C; Kyprianidou P; Pelecanou M; Papadopoulos M
Mol Pharm; 2012 Jun; 9(6):1681-92. PubMed ID: 22519912
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek.
Wallace AM; Hoh CK; Darrah DD; Schulteis G; Vera DR
Nucl Med Biol; 2007 Oct; 34(7):849-53. PubMed ID: 17921035
[TBL] [Abstract][Full Text] [Related]
11. Phytate technetium-99m versus dextran 500 technetium-99m in the sentinel lymph node biopsy.
Paiva GR; Filho RS; Ferreira LM; Wagner J; Nogueira SA; Novo NF; Juliano Y; Rocha JL
Acta Radiol; 2006 Feb; 47(1):65-70. PubMed ID: 16498935
[TBL] [Abstract][Full Text] [Related]
12. Size and specificity of radiopharmaceuticals for sentinel lymph node detection.
Núñez EG; Teodoro R; Wiecek DP; da Silva NG; Martinelli JR; de Oliveira Filho RS
Acta Radiol; 2011 Sep; 52(7):774-8. PubMed ID: 21558148
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification.
Edreira MM; Colombo LL; Perez JH; Sajaroff EO; de Castiglia SG
Nucl Med Commun; 2001 May; 22(5):499-504. PubMed ID: 11388570
[TBL] [Abstract][Full Text] [Related]
14. Mannosylated dextran derivatives labeled with fac-[M(CO)₃]+ (M = (99m)Tc, Re) for specific targeting of sentinel lymph node.
Morais M; Subramanian S; Pandey U; Samuel G; Venkatesh M; Martins M; Pereira S; Correia JD; Santos I
Mol Pharm; 2011 Apr; 8(2):609-20. PubMed ID: 21299250
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node identification in breast cancer: a comparison study of deep versus superficial injection of radiopharmaceutical.
Clímaco F; Coelho-Oliveira A; Djahjah MC; Gutfilen B; Correia AH; Noé R; da Fonseca LM
Nucl Med Commun; 2009 Jul; 30(7):525-32. PubMed ID: 19451838
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
[TBL] [Abstract][Full Text] [Related]
17. Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping.
Yamaguchi A; Hanaoka H; Pirmettis I; Uehara T; Tsushima Y; Papadopoulos M; Arano Y
Mol Pharm; 2015 Feb; 12(2):514-9. PubMed ID: 25423619
[TBL] [Abstract][Full Text] [Related]
18. [Intraoperative injection of technetium-99m-dextran 500 for the identification of sentinel lymph node in breast cancer].
Delazeri GJ; Xavier NL; Menke CH; Bittelbrunn AC; Spiro BL; Mosmann MP; Graudenz MS
Rev Bras Ginecol Obstet; 2010 Oct; 32(10):486-90. PubMed ID: 21271155
[TBL] [Abstract][Full Text] [Related]
19. A new agent, blue and radioactive, for sentinel node detection.
El-Tamer M; Saouaf R; Wang T; Fawwaz R
Ann Surg Oncol; 2003 Apr; 10(3):323-9. PubMed ID: 12679319
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification.
Takagi K; Uehara T; Kaneko E; Nakayama M; Koizumi M; Endo K; Arano Y
Nucl Med Biol; 2004 Oct; 31(7):893-900. PubMed ID: 15464391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
